BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee C, Nucci MR. Endometrial stromal sarcoma - the new genetic paradigm. Histopathology 2015;67:1-19. [DOI: 10.1111/his.12594] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Elmajee M, Osman K, Dermanis A, Duffaydar H, Soon WC, czyz M. A literature Review: The genomic landscape of spinal chondrosarcoma and potential diagnostic, prognostic & therapeutic implications. Interdisciplinary Neurosurgery 2022;30:101651. [DOI: 10.1016/j.inat.2022.101651] [Reference Citation Analysis]
2 de Almeida BC, Dos Anjos LG, Dobroff AS, Baracat EC, Yang Q, Al-Hendy A, Carvalho KC. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines 2022;10:2567. [PMID: 36289829 DOI: 10.3390/biomedicines10102567] [Reference Citation Analysis]
3 Namjoshi A, Wong DD, Gill J. A rare case of metastatic endometrial stromal sarcoma mimicking primary breast carcinoma: a diagnostic pitfall. Pathology 2022. [DOI: 10.1016/j.pathol.2022.08.006] [Reference Citation Analysis]
4 Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecol Oncol 2022:S0090-8258(22)00515-7. [PMID: 36114030 DOI: 10.1016/j.ygyno.2022.07.031] [Reference Citation Analysis]
5 Sharma A, Sancheti S, Somal P, Sali A, Dwivedi A, Tahlan S. The Flower Vase Uterus: A Rare Presentation. Indian J Gynecol Oncolog 2022;20:34. [DOI: 10.1007/s40944-022-00636-x] [Reference Citation Analysis]
6 Bhatt A, Mishra S, Glehen O. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site—a Review. Indian J Surg Oncol 2022. [DOI: 10.1007/s13193-022-01612-9] [Reference Citation Analysis]
7 Alkanat NE, Uner A, Usubutun A. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis. Int J Surg Pathol 2022;:10668969221098087. [PMID: 35506912 DOI: 10.1177/10668969221098087] [Reference Citation Analysis]
8 Kim Y, Kim D, Sung WJ, Hong J. High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies. Front Immunol 2022;13:837004. [PMID: 35242139 DOI: 10.3389/fimmu.2022.837004] [Reference Citation Analysis]
9 Mayr D, Horn L, Hiller GGR, Höhn AK, Schmoeckel E. Endometriale und weitere seltene uterine Sarkome. Pathologe 2022;43:183-195. [DOI: 10.1007/s00292-022-01072-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mejbel HA, Harada S, Stevens TM, Huang X, Netto GJ, Mackinnon AC, Al Diffalha S. Spindle Cell Sarcoma of the Uterus Harboring MEIS1::NCOA1 Fusion Gene and Mimicking Endometrial Stromal Sarcoma. Int J Surg Pathol 2022;:10668969221098081. [PMID: 35477326 DOI: 10.1177/10668969221098081] [Reference Citation Analysis]
11 Yoshida H, Kikuchi A, Tsuda H, Sakamoto A, Fukunaga M, Kaku T, Yoshida M, Shikama A, Kogata Y, Terao Y, Tanikawa M, Yasuoka T, Chiyoda T, Miyamoto T, Okadome M, Nakamura T, Enomoto T, Konno Y, Yahata H, Hirata Y, Aoki Y, Tokunaga H, Usui H, Yaegashi N. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese Clinical Oncology Group. Hum Pathol 2022:S0046-8177(22)00073-9. [PMID: 35339567 DOI: 10.1016/j.humpath.2022.03.007] [Reference Citation Analysis]
12 Yamaguchi K. Personalized Treatment in Uterine Sarcoma. Personalization in Gynecologic Oncology 2022. [DOI: 10.1007/978-981-19-4711-7_4] [Reference Citation Analysis]
13 Niu S, Zheng W. Endometrial stromal tumors: Diagnostic updates and challenges. Seminars in Diagnostic Pathology 2022. [DOI: 10.1053/j.semdp.2022.01.004] [Reference Citation Analysis]
14 Akaev I, Yeoh CC, Rahimi S. Update on Endometrial Stromal Tumours of the Uterus. Diagnostics (Basel) 2021;11:429. [PMID: 33802452 DOI: 10.3390/diagnostics11030429] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
15 Maestro Durán MA, Alvarez Devesa L, Fraga Manteiga D. Sarcoma del estroma endometrial como masa retroperitoneal. Revista Argentina de Radiología / Argentinian Journal of Radiology 2021;85:024-026. [DOI: 10.1055/s-0040-1716382] [Reference Citation Analysis]
16 Marani C, Akaev I, Yeoh CC, Walsh E, Rahimi S. Cervical malignant mixed mesonephric tumour: A case report with local recurrence after six-years and next-generation sequencing analysis with particular reference to the ataxia telangiectasia mutated gene. Exp Ther Med 2021;21:394. [PMID: 33680116 DOI: 10.3892/etm.2021.9825] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Selenica P, Conlon N, Gonzalez C, Frosina D, Jungbluth AA, Beets-Tan RGH, Rao MK, Zhang Y, Benayed R, Ladanyi M, Solit DB, Chiang S, Hyman DM, Hensley ML, Soslow RA, Weigelt B, Murali R. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation. Am J Surg Pathol 2021;45:77-92. [PMID: 32889887 DOI: 10.1097/PAS.0000000000001572] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
18 Horn LC, Höhn AK, Denschlag D, Follmann M, Schmidt D. [Interdisciplinary S2k guidelines on the diagnosis and treatment of uterine sarcomas-recommendations for surgical pathology]. Pathologe 2020;41:621-33. [PMID: 32940744 DOI: 10.1007/s00292-020-00826-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kim J, Heo SH, Shin SS, Jeong YY. MRI Findings and Differential Diagnosis of Benign and Malignant Tumors of the Uterine Corpus. J Korean Soc Radiol 2021;82:1103. [DOI: 10.3348/jksr.2021.0116] [Reference Citation Analysis]
20 Croce S, Hostein I, McCluggage WG. NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms. Genes Chromosomes Cancer 2021;60:147-59. [PMID: 33099837 DOI: 10.1002/gcc.22910] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
21 Micci F, Heim S, Panagopoulos I. Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma. Genes Chromosomes Cancer 2021;60:160-7. [PMID: 33099834 DOI: 10.1002/gcc.22907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
22 Chang B, Bai Q, Liang L, Ge H, Yao Q. Recurrent uterine tumors resembling ovarian sex-cord tumors with the growth regulation by estrogen in breast cancer 1-nuclear receptor coactivator 2 fusion gene: a case report and literature review. Diagn Pathol. 2020;15:110. [PMID: 32921307 DOI: 10.1186/s13000-020-01025-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Libertini M, Hallin M, Thway K, Noujaim J, Benson C, van der Graaf W, Jones RL. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy. Int J Surg Pathol 2021;29:4-20. [PMID: 32909482 DOI: 10.1177/1066896920958120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Yoon JY, Rosenbaum JN, Vergara N, Cohen RB, Wilson RB. Bayesian approach to interpreting somatic cancer sequencing data: a case in point. J Clin Pathol 2020:jclinpath-2020-206895. [PMID: 32855180 DOI: 10.1136/jclinpath-2020-206895] [Reference Citation Analysis]
25 Capozzi VA, Monfardini L, Ceni V, Cianciolo A, Butera D, Gaiano M, Berretta R. Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm. J Obstet Gynaecol Res 2020;46:2221-36. [PMID: 32830415 DOI: 10.1111/jog.14436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
26 Patel SB, McCormack C, Hodge JC. Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation? J Clin Pathol 2020;73:830-5. [PMID: 32385140 DOI: 10.1136/jclinpath-2020-206432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Goebel EA, Hernandez Bonilla S, Dong F, Dickson BC, Hoang LN, Hardisson D, Lacambra MD, Lu FI, Fletcher CDM, Crum CP, Antonescu CR, Nucci MR, Kolin DL. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A Morphologic and Molecular Study of 26 Cases Confirms Recurrent NCOA1-3 Rearrangement. Am J Surg Pathol. 2020;44:30-42. [PMID: 31464709 DOI: 10.1097/pas.0000000000001348] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
28 Rahimi S, Akaev I, Marani C, Chopra M, Yeoh CC. Immunohistochemical Expression of Different Subtypes of Cytokeratins by Endometrial Stromal Sarcoma. Appl Immunohistochem Mol Morphol 2019;27:466-70. [PMID: 29406332 DOI: 10.1097/PAI.0000000000000642] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
29 Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
30 Bi Q, Wu K, Lv F, Xiao Z, Xiong Y, Shen Y. The value of clinical parameters combined with magnetic resonance imaging (MRI) features for preoperatively distinguishing different subtypes of uterine sarcomas: An observational study (STROBE compliant). Medicine (Baltimore) 2020;99:e19787. [PMID: 32311989 DOI: 10.1097/MD.0000000000019787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 McCluggage WG, Lee CH. YWHAE-NUTM2A/B Translocated High-grade Endometrial Stromal Sarcoma Commonly Expresses CD56 and CD99. Int J Gynecol Pathol 2019;38:528-32. [PMID: 30252726 DOI: 10.1097/PGP.0000000000000554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
32 Arias-Stella JA 3rd, Benayed R, Oliva E, Young RH, Hoang LN, Lee CH, Jungbluth AA, Frosina D, Soslow RA, Antonescu CR, Ladanyi M, Chiang S. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors. Am J Surg Pathol 2019;43:382-8. [PMID: 30489320 DOI: 10.1097/PAS.0000000000001196] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 16.5] [Reference Citation Analysis]
33 Bhatt A, Parikh L, Mishra S, Glehen O. Approach to a Patient with Peritoneal Metastases with Unknown Primary Site: Focus on Histopathological Evaluation. Pathology of Peritoneal Metastases 2020. [DOI: 10.1007/978-981-15-3773-8_11] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Mishra S, Sinukumar S, Jumale N, Parikh L, Bhatt A, Glehen O. Rare Peritoneal Tumours: Histopathological Diagnosis and Patterns of Peritoneal Dissemination. Pathology of Peritoneal Metastases 2020. [DOI: 10.1007/978-981-15-3773-8_10] [Reference Citation Analysis]
35 Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
36 Parra-Herran C, Howitt BE. Uterine Mesenchymal Tumors: Update on Classification, Staging, and Molecular Features. Surg Pathol Clin 2019;12:363-96. [PMID: 31097109 DOI: 10.1016/j.path.2019.01.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
37 Huang YL, Ueng SH, Chen K, Huang YT, Lu HY, Ng KK, Chang TC, Lai CH, Lin G. Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma. Cancer Imaging 2019;19:63. [PMID: 31514752 DOI: 10.1186/s40644-019-0247-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
38 Astolfi A, Fiore M, Melchionda F, Indio V, Bertuccio SN, Pession A. BCOR involvement in cancer. Epigenomics 2019;11:835-55. [PMID: 31150281 DOI: 10.2217/epi-2018-0195] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 25.3] [Reference Citation Analysis]
39 Low SYY, Kuick CH, Seow WY, Bte Syed Sulaiman N, Chen H, Lian DWQ, Chang KTE, Tan EEK, Soh SY, Tan GIL, Ng LP, Seow WT, Low DCY. Primary paediatric epidural sarcomas: molecular exploration of three cases. BMC Cancer 2019;19:182. [PMID: 30819134 DOI: 10.1186/s12885-019-5368-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Dickson BC. Beyond Smooth Muscle-Other Mesenchymal Neoplasms of the Uterus. Surg Pathol Clin 2019;12:107-37. [PMID: 30709439 DOI: 10.1016/j.path.2018.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Efared B, Sidibé IS, Erregad F, Hammas N, Chbani L, El Fatemi H. Extra-uterine low grade endometrioid stromal sarcoma arising from ovarian endometriosis: a case report and review of the literature. Gynecol Oncol Res Pract 2019;6:2. [PMID: 30723546 DOI: 10.1186/s40661-019-0067-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
42 Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
43 Murdock TA, Veras EFT, Kurman RJ, Mazur MT. Mesenchymal Tumors and Other Rare Neoplasms. Diagnosis of Endometrial Biopsies and Curettings 2019. [DOI: 10.1007/978-3-319-98608-1_11] [Reference Citation Analysis]
44 Ferreira J, Félix A, Lennerz JK, Oliva E. Recent advances in the histological and molecular classification of endometrial stromal neoplasms. Virchows Arch 2018;473:665-78. [DOI: 10.1007/s00428-018-2470-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
45 Bi Q, Xiao Z, Lv F, Liu Y, Zou C, Shen Y. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma. Acad Radiol 2018;25:993-1002. [PMID: 29422425 DOI: 10.1016/j.acra.2018.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
46 Michael Straughn J Jr, Boitano T, Smith HJ, Dilley SE, Liang MI, Novak L. Treatment of low-grade endometrial stromal sarcoma in a nulligravid woman. Gynecol Oncol 2018;151:6-9. [PMID: 29887484 DOI: 10.1016/j.ygyno.2018.05.027] [Reference Citation Analysis]
47 Baniak N, Adams S, Chibbar R, Lee CH, Kanthan R. Hepatic endometrial stromal sarcoma. Pathol Res Pract 2018;214:1726-31. [PMID: 29843927 DOI: 10.1016/j.prp.2018.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Li HM, Liu J, Qiang JW, Gu WY, Zhang GF, Ma FH. Endometrial Stromal Sarcoma of the Uterus: Magnetic Resonance Imaging Findings Including Apparent Diffusion Coefficient Value and Its Correlation With Ki-67 Expression. Int J Gynecol Cancer 2017;27:1877-87. [PMID: 28906310 DOI: 10.1097/IGC.0000000000001114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
49 Mariño-enriquez A, Lauria A, Przybyl J, Ng TL, Kowalewska M, Debiec-rychter M, Ganesan R, Sumathi V, George S, Mccluggage WG, Nucci MR, Lee C, Fletcher JA. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas. American Journal of Surgical Pathology 2018;42:335-41. [DOI: 10.1097/pas.0000000000000993] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 23.3] [Reference Citation Analysis]
50 Hoang L, Chiang S, Lee C. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 2018;50:162-77. [DOI: 10.1016/j.pathol.2017.11.086] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 17.0] [Reference Citation Analysis]
51 Yang EJ, Howitt BE, Fletcher CDM, Nucci MR. Solitary fibrous tumour of the female genital tract: a clinicopathological analysis of 25 cases. Histopathology 2018;72:749-59. [DOI: 10.1111/his.13430] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
52 McCluggage WG, Oliva E. Gynaecological pathology: problematic areas, new concepts and emerging developments. Pathology 2018;50:119-21. [PMID: 29258703 DOI: 10.1016/j.pathol.2017.11.085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Matias-Guiu X, Stewart CJR. Endometriosis-associated ovarian neoplasia. Pathology 2018;50:190-204. [PMID: 29241974 DOI: 10.1016/j.pathol.2017.10.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 14.2] [Reference Citation Analysis]
54 Busca A, Parra-Herran C. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis. Adv Anat Pathol 2017;24:354-61. [PMID: 28787279 DOI: 10.1097/PAP.0000000000000164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
55 Roy M, Kumar S, Bhatla N, Ray MD, Kumar L, Jain D, Phulware R, Mathur SR. Androgen Receptor Expression in Endometrial Stromal Sarcoma: Correlation With Clinicopathologic Features. International Journal of Gynecological Pathology 2017;36:420-7. [DOI: 10.1097/pgp.0000000000000353] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
56 Hardell E, Josefson S, Ghaderi M, Skeie-jensen T, Westbom-fremer S, Cheek EH, Bell D, Selling J, Schoolmeester JK, Måsbäck A, Davidson B, Carlson JW. Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas. American Journal of Surgical Pathology 2017;41:1231-7. [DOI: 10.1097/pas.0000000000000894] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
57 Ritterhouse LL, Howitt BE. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors. Surg Pathol Clin 2016;9:405-26. [PMID: 27523969 DOI: 10.1016/j.path.2016.04.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
58 Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, Hensley ML, Park KJ, Hollmann TJ, Hameed MR, Antonescu CR, Soslow RA, Chiang S. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma. Am J Surg Pathol 2017;41:12-24. [PMID: 27631520 DOI: 10.1097/PAS.0000000000000721] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
59 Vroobel KM, Karawita TS, Wilkinson N. New developments in endometrial stromal sarcoma. Diagnostic Histopathology 2017;23:311-22. [DOI: 10.1016/j.mpdhp.2017.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
60 Sugita S, Arai Y, Aoyama T, Asanuma H, Mukai W, Hama N, Emori M, Shibata T, Hasegawa T. NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma. Human Pathology 2017;65:225-30. [DOI: 10.1016/j.humpath.2017.01.012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
61 Przybyl J, Kowalewska M, Quattrone A, Dewaele B, Vanspauwen V, Varma S, Vennam S, Newman AM, Swierniak M, Bakuła-Zalewska E, Siedlecki JA, Bidzinski M, Cools J, van de Rijn M, Debiec-Rychter M. Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas. JCI Insight 2017;2:94033. [PMID: 28570276 DOI: 10.1172/jci.insight.94033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
62 Horng HC, Wen KC, Wang PH, Chen YJ, Yen MS, Ng HT; Taiwan Association of Gynecology Systematic Review Group. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review. Taiwan J Obstet Gynecol. 2016;55:472-479. [PMID: 27590366 DOI: 10.1016/j.tjog.2016.04.034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
63 Singh N, Gilks CB. The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century. Histopathology 2017;70:56-69. [PMID: 27960241 DOI: 10.1111/his.13080] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
64 Kubo T, Sugita S, Wada R, Kikuchi N, Iwasaki M, Ito Y, Sugawara T, Fujita H, Emori M, Tanaka R, Hirano H, Saito T, Hasegawa T. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma. Diagn Pathol 2017;12:26. [PMID: 28288693 DOI: 10.1186/s13000-017-0615-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
65 Miller EM, Fu Y, Vera RB, Goldberg GL, Karabakhtsian RG. Uterine sarcoma with ambiguous histomorphology: A case report. Gynecol Oncol Rep 2017;20:30-3. [PMID: 28271093 DOI: 10.1016/j.gore.2017.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
66 Li J, Xing X, Li D, Zhang B, Mutch DG, Hagemann IS, Wang T. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma. Neoplasia 2017;19:100-11. [PMID: 28088687 DOI: 10.1016/j.neo.2016.12.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
67 Howitt BE, Nucci MR. Molecular Pathology of Uterine Mesenchymal Tumors. Molecular Pathology Library 2017. [DOI: 10.1007/978-3-319-57985-6_11] [Reference Citation Analysis]
68 Ordóñez JL, Osuna D, Madoz-gúrpide J, de Álava E. Molecular Pathology of Bone and Soft Tissue Tumors. The Molecular Basis of Human Cancer 2017. [DOI: 10.1007/978-1-59745-458-2_34] [Reference Citation Analysis]
69 Richmond AM, Rohrer AJ, Davidson SA, Post MD. Low-grade endometrial stromal sarcoma with extensive sex cord differentiation, heterologous elements, and complex atypical hyperplasia: Case report and review of literature. Gynecol Oncol Rep. 2016;19:34-38. [PMID: 28054022 DOI: 10.1016/j.gore.2016.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
70 Barr FG. Fusion genes in solid tumors: the possibilities and the pitfalls. Expert Rev Mol Diagn 2016;16:921-3. [PMID: 27550633 DOI: 10.1080/14737159.2016.1220835] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
71 Stewart CJ, Crook M, Tan A. SF1 immunohistochemistry is useful in differentiating uterine tumours resembling sex cord-stromal tumours from potential histological mimics. Pathology. 2016;48:434-440. [PMID: 27311867 DOI: 10.1016/j.pathol.2016.03.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
72 Hodge JC, Bedroske PP, Pearce KE, Sukov WR. Molecular Cytogenetic Analysis of JAZF1, PHF1, and YWHAE in Endometrial Stromal Tumors: Discovery of Genetic Complexity by Fluorescence in Situ Hybridization. J Mol Diagn 2016;18:516-26. [PMID: 27154512 DOI: 10.1016/j.jmoldx.2016.02.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
73 Li X, Anand M, Haimes JD, Manoj N, Berlin AM, Kudlow BA, Nucci MR, Ng TL, Stewart CJR, Lee C. The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma. Histopathology 2016;69:551-9. [DOI: 10.1111/his.12966] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
74 Hrzenjak A. JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas. Orphanet J Rare Dis 2016;11:15. [PMID: 26879382 DOI: 10.1186/s13023-016-0400-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
75 Raine-bennett T, Tucker L, Zaritsky E, Littell RD, Palen T, Neugebauer R, Axtell A, Schultze PM, Kronbach DW, Embry-schubert J, Sundang A, Bischoff K, Compton-phillips AL, Lentz SE. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation. Obstetrics & Gynecology 2016;127:29-39. [DOI: 10.1097/aog.0000000000001187] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 12.7] [Reference Citation Analysis]
76 Nucci MR. Practical issues related to uterine pathology: endometrial stromal tumors. Mod Pathol 2016;29:S92-S103. [DOI: 10.1038/modpathol.2015.140] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]